Abstract: The invention encompasses compounds as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The invention is directed to a method for forming a flexible electro-optic film. The method comprises steps of providing a first substrate having a conductive layer formed thereon and then forming a first locating structure over the conductive layer, wherein the locating structure includes target regions and periphery regions. The surface tension of the target regions is difference from that of the periphery regions. Thereafter, an electro-optic medium placing process for forming an electro-optic droplet on each of the target regions is performed. A solidifying process for forming a capsule wall covering the electro-optic droplet on each of the target regions is performed. The first substrate is laminated with a second substrate.

Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: A method of manufacturing a display panel is described. A substrate is provided. A wall structure is formed on the substrate to define several microcups. A display medium is filled into the microcups. Thereafter, a sealing layer is formed over the microcups filled with the display medium, wherein the sealing layer includes a first material that is immiscible with the display medium and a second material that is miscible with the display medium. A treatment process is performed such that the first material is solidified to form a solidifying layer while the second material miscible in the display medium undergoes a polymerization induced phase separation reaction so as to precipitate in the display medium.

Abstract: A transflective electrophoretic display and a method for manufacturing the same are proposed. The transflective electrophoretic display including a top substrate and a bottom substrate, multiple separating walls disposed between the top and bottom substrates, a transflective film, and an electrophoretic display medium, can be designed to display colors by using multicolor electrophoretic display media or color filters. The display can be viewed with or without ambient light by adopting a backlight module, as well as to improve the overall display quality.

Abstract: The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Abstract: Apparatus and method for allowing a test script to be played back correctly in a locale of different test language. The invention uses a synonymy dictionary storing the different appearances of the property value of a property in an object of a software product to be tested in different test locales; and compares the property value of the property in the object of the software product to be tested to the corresponding property value pre-recorded in a test script to detect whether they match each other.

Abstract: The present invention provides novel N-substituted fluorooxindoles having the general Formula I wherein the wavy bond represents the racemate, the (R)-enantiomer or the (S)-enantiomer and m, n, p, q, A, B, D, Q, X, and Z are as defined below, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels.

Abstract: The present disclosure relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Abstract: A flexible reflective display device and a manufacturing method for the same are disclosed. The present invention is formed by introducing flexible printed circuit board manufacture technology together with flexible display technology. The flexible reflective display device, comprising an upper substrate, a display medium layer formed on the upper substrate, and a lower flexible printed circuit substrate; a first electrode layer formed on the upper substrate in the interface between the upper substrate and the display medium layer; a second electrode layer formed on the flexible printed circuit substrate; and an adhesive layer formed between the display medium layer and the flexible printed circuit substrate.

Abstract: A display-enabled electronic system. The display-card electronic comprises an external device and card-type device receiving the external device. The external device provides a data signal. The card-type device comprises a card body, at least one image display unit, and an interface. The card body comprises a display surface and a receiving portion. The image display unit disposed in the display surface displays corresponding images in response to the data signal. The interface disposed in the receiving portion, electrically connects to the external device to transmit the data signal.

Abstract: Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds.

Abstract: Methods of fabricating liquid crystal displays. A substrate with a first electrode layer thereon is provided. A patterned barrier layer is formed to generate a plurality of pixel regions. A liquid crystal layer is filled into each pixel region. A monomer layer is filled into each pixel region over the liquid crystal layer. The monomer layer is polymerized to form a polymer layer phase separated from the liquid crystal layer.

Abstract: A modulized display component and a manufacturing method for the same are disclosed in this invention. The display component of this invention is designed according to a modulization concept so that it can be attached to any driving circuit layer. Further, various manufacturing techniques can be used to form the alignment layers and protective layers in order to fabricate a trans-reflective, reflective, or transmissive color displaying component.

Abstract: A transflective electrophoretic display and a method for manufacturing the same are proposed. The transfiective electrophoretic display including a top substrate and a bottom substrate, multiple separating walls disposed between the top and bottom substrates, a transflective film, and an electrophoretic display medium, can be designed to display colors by using multicolor electrophoretic display media or color filters. The display can be viewed with or without ambient light by adopting a backlight module, as well as to improve the overall display quality.

Abstract: A color cholesteric liquid crystal display device and a manufacturing method for the same are proposed in the present invention. A display device is made via an inkjet process and two ultraviolet exposure processes. The simple inkjet process is used, and an ultraviolet exposure is performed twice to provide a color cholesteric liquid crystal display device having a bistable feature. The display of the present invention is a flexible color cholesteric liquid crystal display device.

Abstract: A color cholesteric liquid crystal display device and a manufacturing method for the same are proposed. A color cholesteric liquid crystal display device has a bistable single-layer or stacked structure. The display is made of cholesteric liquid crystal material via an inkjet process and ultraviolet exposure processes that induce a phase separation reaction. In addition, the display provided in the present invention enhances the reflective brightness. Furthermore, the techniques of the present invention can be applied to make flexible color cholesteric liquid crystal display devices.